Michael Darda, chief economist and market strategist at MKM Partners, was no fan of the stock market when it was registering record highs. “Blinded by liquidity and false expectations of the proverbia...
Tag: Healthcare/Life Sciences
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion
Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...
Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.
Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
Merck Pushes Forward With Potential Deal for Seagen
Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year. The Wall Stre...
This dividend fund is down 3% vs. S&P’s 20% drop. Here are its top stock picks
By now even the most ardent tech and growth-stock enthusiasts realize the bull market is over. John Kornitzer’s approach to selecting high-quality stocks for the Buffalo Flexible Income Fund is one th...
Energy and these 2 other sectors led the S&P 500. Now they’ve tanked. Here’s why that could be good for the stock market.
An unwind of the stock market’s best performing sectors had to happen eventually. And that may be just what this bear market ordered, according to Jonathan Krinsky, chief market technician at BTIG. Si...
Novavax’s New Covid-19 Vaccine Might Be Late to the Party
It’s one thing to arrive fashionably late to a party, it’s another thing to waltz in when the last guests are stumbling out the door. For Novavax , which on Tuesday cleared a key step toward U.S. Food...
Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.
Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...
Hot stocks may bring an initial thrill, but they’ll break your heart
My father was born in 1936 in Brooklyn. He attended Erasmus High School, earned a degree in chemical engineering from Brooklyn Polytechnic High School and then went on to study dentistry at New York ...
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...
Warren Buffett’s Berkshire Hathaway reveals new stakes in Paramount, Citigroup
OMAHA, Neb. — Warren Buffett’s company on Monday revealed all the investment moves it made in the first quarter, when it spent more than $51 billion on stocks. But Buffett had already shared the bigge...
GoodRx Beat Quartely Estimates. Here’s Why the Stock Is Falling.
Text size GoodRx had a strong first quarter but effectively removed 2022 guidance. Piksel/Dreamstime News that a large grocer is no longer accepting GoodRx’s pharmacy discount cards has wrecked the st...
Novavax posts first quarterly profit, but misses expectations
Shares of Novavax Inc. dropped more than 6% in the extended session Monday after the biotech company reported its first profitable quarter, but not by as much as Wall Street expected, and its sales we...
BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine
Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...
These 16 stocks in the S&P 500 crumpled at least 9% a day after the Fed raised rates
One day after U.S. stocks got a reprieve as the Federal Reserve lifted its target range for short-term interest rates by 0.75 percentage point, inflation fears built a new wall of worry to send U.S. s...